mTOR pathway targets are activated in thyroid cancer, and metformin may also inhibit the growth, migration and mesenchymal transition of thyroid cancer cell lines through the mTOR pathway other than the insulin pathway [14]. Here, MTOR is linked to thyroid gland carcinoma.